Coronavirus

Fauci ‘certain’ Americans will need COVID-19 booster shots
Aug29

Fauci ‘certain’ Americans will need COVID-19 booster shots

Dr. Anthony Fauci on Sunday said that he was “certain” that Americans would need booster shots of the COVID-19 vaccine but how long they’ll need to wait to get them could change. “I’m certain we’re going to need that third dose, looking at the data that we’re seeing,” the White House chief medical advisor said on NBC’s “Meet the Press.” Fauci said that the White House was moving ahead with plans to give out the boosters eight months...

Read More
A grim warning from Israel: Vaccination blunts, but does not defeat Delta
Aug21

A grim warning from Israel: Vaccination blunts, but does not defeat Delta

                “Now is a critical time,” Israeli Minister of Health Nitzan Horowitz said as the 56-year-old got a COVID-19 booster shot on 13 August, the day his country became the first nation to offer a third dose of vaccine to people as young as age 50. “We’re in a race against the pandemic.” His message was meant for his fellow Israelis, but it is a warning to the world. Israel has among...

Read More
Delta variant rises to dominance in La Plata, Archuleta counties
Aug07

Delta variant rises to dominance in La Plata, Archuleta counties

People who are unvaccinated experiencing surge of cases By Shannon Mullane Herald Staff Writer Saturday, Aug. 7, 2021 5:00 Vanessa Taylor, 47, said she is still monitoring her recovery from COVID-19 six weeks after her original diagnosis. She caught the virus from her daughter, Rhyse, 9. (Jerry McBride/Durango Herald) The headaches, coughing and body aches started in late June for Durango resident Vanessa Taylor. When she went to the...

Read More
NRx Pharmaceuticals Announces Emergency Use Authorization Of ZYESAMI In Nation Of Georgia
Jul28

NRx Pharmaceuticals Announces Emergency Use Authorization Of ZYESAMI In Nation Of Georgia

NRx Pharmaceuticals (NASDAQ:NRXP) (NRx), a clinical stage, global biopharmaceutical company, today announced that the Nation of Georgia’s Prime Minister and Minister of Health have issued an Emergency Use Authorization for intravenous ZYESAMI™ (aviptadil) for the treatment of Critical COVID-19.   NRx Pharmaceuticals Announces Emergency Use Authorization of ZYESAMI™ (aviptadil) in Nation of Georgia “Lead investigators...

Read More
NRx Pharmaceuticals Announces First Successful Commercial Formulation for ZYESAMI, Enabling Volume Manufacture, Shipping, and Stockpiling of COVID-19 Medication Subject to Regulatory Approval
Jul22

NRx Pharmaceuticals Announces First Successful Commercial Formulation for ZYESAMI, Enabling Volume Manufacture, Shipping, and Stockpiling of COVID-19 Medication Subject to Regulatory Approval

NRx Pharmaceuticals (NRx) (NASDAQ:NRXP) announced today it has validated the first commercial formulation of ZYESAMI™ (aviptadil) for intravenous use, allowing for high volume manufacture, with an anticipated one year or greater stability, under appropriate storage conditions. Simultaneously, NRx has achieved a 30-to-50-fold increase in its manufactured lot size of aviptadil, with a concurrent 90% reduction in the cost of its peptide...

Read More
CDC Relaxes COVID-19 Mask Guidelines For Vaccinated Americans
May01

CDC Relaxes COVID-19 Mask Guidelines For Vaccinated Americans

The Centers for Disease Control and Prevention released new coronavirus guidelines for vaccinated Americans on Tuesday that include updated recommendations on mask-wearing while outdoors. The new guidance says people who have been fully vaccinated and have waited at least two weeks after their last shot do not need to wear masks outdoors when alone, with members of their household or in small gatherings. They may also forgo masks...

Read More
Relief Reports 2020 Financial Results and Provides Business Update
Apr16

Relief Reports 2020 Financial Results and Provides Business Update

GENEVA, SWITZERLAND / ACCESSWIRE / April 15, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) (“Relief” or the “Company”), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat COVID-19 induced lung injury, today announced its 2020 financial results for the year ended December 31, 2020 and provided a business update. “The past year...

Read More
RELIEF CONFIRMS RELEASE OF 60-DAY Findings
Apr13

RELIEF CONFIRMS RELEASE OF 60-DAY Findings

RELIEF CONFIRMS RELEASE OF 60-DAY FINDINGS FROM PHASE 2B/3 CLINICAL TRIAL OF INTRAVENOUS RLF-100™ (AVIPTADIL) 30 March 2021 60-day results have been presented by Relief’s partner, NeuroRx, Inc. Geneva, Switzerland, March 30, 2021 – RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (“Relief”), a biopharmaceutical company with its lead compound RLF-100™ (aviptadil) in advanced clinical development to treat critically-ill COVID-19...

Read More
Why has Covid’s toll been surprisingly low across much of Africa and Asia?
Mar10

Why has Covid’s toll been surprisingly low across much of Africa and Asia?

By David Leonhardt Good morning. Why has Covid’s toll been surprisingly low across much of Africa and Asia? ‘An epidemiological whodunit’ It’s one of the biggest mysteries about Covid-19: Why has the death toll been relatively low across much of Africa and Asia? The virus has killed a fraction of as many people on those continents — despite their relative lack of resources — as it has in Europe or the U.S.: This isn’t how public...

Read More
NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19
Mar03

NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19

NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19 Treated with High Flow Nasal Oxygen at 28-Day Interim Endpoint NeuroRx to File for Emergency Use Authorization in This Patient Population if Positive Results Continue to be Demonstrated at Day-60 Endpoint in Line with FDA’s New Guidance NEWS PROVIDED BY NeuroRx ...

Read More
NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™
Feb09

NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™

NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™ in Reducing Hospital Stay Among Patients with Respiratory Failure due to Critical COVID-19 If Authorized for Use, ZYESAMI™ Would be First Treatment Specifically for Critically Ill Patients with Respiratory Failure RADNOR, Pa. and GENEVA, Feb. 9, 2021 /PRNewswire/ — NeuroRx, Inc. and Relief Therapeutics Holdings...

Read More
RELIEF AFFIRMS INITIATION OF PHASE 2/3
Feb09

RELIEF AFFIRMS INITIATION OF PHASE 2/3

RELIEF AFFIRMS INITIATION OF PHASE 2/3 TRIAL OF INHALED RLF-100™ (AVIPTADIL; ZYESAMI™) IN SEVERE COVID-19 PATIENTS 08 February 2021 Top-line data from intravenous RLF-100™ phase 2b/3 trial expected to be released this month Geneva, Switzerland, February 08, 2021 – RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (“Relief” or the “Company”) affirms that its collaboration partner NeuroRx, Inc. has...

Read More
A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year
Jan17

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year Medical staff examine a patient in the Covid-19 intensive care unit at United Memorial Medical Center in Houston on Nov. 16, 2020. Go Nakamura | Getty Images KEY POINTS Relief Therapeutics Chairman Ram Selvaraju told CNBC that Relief Therapeutics and NeuroRx had been in contact with the HSS’ Operation Warp Speed, and expects topline data...

Read More
Dr. Fauci Says When We’ll Get Back to Normal
Jan13

Dr. Fauci Says When We’ll Get Back to Normal

Dr. Fauci Says When We’ll Get Back to Normal With COVID-19 deaths surpassing 4,000 Americans on some days, you probably want protection. You want your vaccine. But reports across the nation indicate that some people are having a hard time getting theirs. At this rate, when will enough people be vaccinated so that we can have herd immunity and get back to some level of “normality?” Dr. Anthony Fauci, the...

Read More
A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year
Jan07

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year KEY POINTS Relief Therapeutics Chairman Ram Selvaraju told CNBC that Relief Therapeutics and NeuroRx had been in contact with the HSS’ Operation Warp Speed, and expects topline data from its late-stage trial of RLF-100 in January. Relief Therapeutics had a market cap of less than 100 million Swiss francs ($113 million) at the end of July,...

Read More
First U.S. Case Of New Covid Mutation Discovered In Colorado
Jan07

First U.S. Case Of New Covid Mutation Discovered In Colorado

First U.S. Case Of New Covid Mutation Discovered In Colorado A new, highly contagious coronavirus variant that was first identified in Britain has reached the United States, officials in Colorado confirmed Tuesday, reporting the first known U.S. case of the strain more than two weeks after it was discovered — a worrying development as Covid-19 infections and deaths climb nationwide. KEY FACTS The variant was discovered in a man in his...

Read More
New Years Around The World
Jan01

New Years Around The World

New year, new rules: World celebrates 2021 through COVID restrictions By JOSEPH WILKINSON NEW YORK DAILY NEWS | DEC 31, 2020 AT 6:57 PM Billions of people around the world celebrated the beginning of 2021 on Friday despite varying coronavirus restrictions. New Zealanders had it first and best, celebrating as normal because the country has no active COVID-19 cases. People in Manila, Philippines, watch a drone show during New...

Read More
Relief Therapeutics Hldg AG (OTC: RLFTF) Gaining as RLF-100 (aviptadil) Top Line Data Looms
Dec28

Relief Therapeutics Hldg AG (OTC: RLFTF) Gaining as RLF-100 (aviptadil) Top Line Data Looms

Relief Therapeutics Hldg AG (OTC: RLFTF) Gaining as RLF-100 (aviptadil) Top Line Data Looms BY JACOB WATSON ON DECEMBER 20, 2020 Microcapdaily continues to cover the exciting story of Relief Therapeutics Holding SA (SWX: RLF) (OTCQB: RLFTF) that skyrocketed up the charts earlier this year as its covid-19 treatment RLF-100 (aviptadil) continues to show significant potential to treat patients who are already in the Intensive Care Unit...

Read More

Challenges to Manufacturing in 2020

As we finish the year 2020, we have learned a lot when it comes to Manufacturing. Many manufacturers have made a pivot to adjust to COVID requests for PPE. Some have seen an opportunity and made a Pivot in a different direction. . How do you know when the time is right to pivot in manufacturing? Join us as we hear from experts around knowing when to pivot. The World Trade Center will discuss import and export matters both in and out...

Read More
Nine New Bills For COVID-19.
Dec10

Nine New Bills For COVID-19.

The Alliance held our December Membership Meeting today with a comprehensive update from SJPH, an outline on the 5 Star Certification timeline, Education opening updates, and grant information.  Here is the LINK to view the recording of the meeting in its entirety. Governor Jared Polis signed nine bills into law yesterday that will provide broad relief to those impacted by COVID-19. Monies will be distributed by local governments and...

Read More